Anmelden Kostenlos registrieren

BioForce Nanosciences Kapitalrendite

Was ist das Kapitalrendite von BioForce Nanosciences?

Kapitalrendite von BioForce Nanosciences Holdings, Inc. ist -762,101.27%

Was ist die Definition von Kapitalrendite?



Die Eigenkapitalrendite ist ein Maß für die Rentabilität eines Unternehmens im Verhältnis zum Buchwert des Eigenkapitals. Sie wird berechnet, indem das Nettoergebnis des Geschäftsjahres durch das gesamte Eigenkapital geteilt wird.

The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.

Kapitalrendite von Unternehmen in Consumer Staples Sektor auf OTC im Vergleich zu BioForce Nanosciences

Was macht BioForce Nanosciences?

BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, and mass merchandisers under the BioForce Eclipse brand, as well as through online and telemarketing. The company is based in Virginia Beach, Virginia.

Unternehmen mit kapitalrendite ähnlich BioForce Nanosciences